159 related articles for article (PubMed ID: 9015179)
21. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
[TBL] [Abstract][Full Text] [Related]
22. Ploidy as a prognostic determinant in surgically treated lung cancer.
Zimmerman PV; Hawson GA; Bint MH; Parsons PG
Lancet; 1987 Sep; 2(8558):530-3. PubMed ID: 2887832
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer.
Pence JC; Kerns BJ; Dodge RK; Iglehart JD
Arch Surg; 1993 Dec; 128(12):1382-90. PubMed ID: 8250713
[TBL] [Abstract][Full Text] [Related]
25. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
27. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.
Choma D; Daurès JP; Quantin X; Pujol JL
Br J Cancer; 2001 Jul; 85(1):14-22. PubMed ID: 11437396
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
[TBL] [Abstract][Full Text] [Related]
29. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of deoxyribonucleic acid aneuploidy in primary non-small-cell lung carcinomas and their metastases.
Liewald F; Hatz R; Storck M; Orend KH; Weiss M; Wulf G; Valet G; Sunder-Plassmann L
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1476-82. PubMed ID: 1331622
[TBL] [Abstract][Full Text] [Related]
31. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E
Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052
[TBL] [Abstract][Full Text] [Related]
32. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung.
Cibas ES; Melamed MR; Zaman MB; Kimmel M
Cancer; 1989 Apr; 63(8):1552-6. PubMed ID: 2924263
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between the nuclear DNA content and the prognosis in squamous cell carcinoma of the lung].
Yamaoka N; Uchiyama Y; Kimino K; Akamine S; Matsuo S
Nihon Kyobu Geka Gakkai Zasshi; 1990 Aug; 38(8):1284-90. PubMed ID: 2230383
[TBL] [Abstract][Full Text] [Related]
34. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
35. Ability of bivariate cytokeratin and deoxyribonucleic acid flow cytometry to determine the biologic aggressiveness of resectable non-small cell lung cancer.
Otsuka H; Funai S; Azumi T; Hara S; Okuno K; Yasutomi M
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):293-8. PubMed ID: 12167789
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
[TBL] [Abstract][Full Text] [Related]
37. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric DNA content and clinical outcome in patients with non-small cell lung cancer given postoperative radiation therapy.
Yu J; Shaeffer J; Zhu A; Kuban DA; el-Mahdi AM; Philput CB
Cytometry; 1993; 14(4):428-32. PubMed ID: 8390343
[TBL] [Abstract][Full Text] [Related]
40. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
